In this article, a multidisciplinary group of breast cancer specialists identified and discussed relevant aspects of the entire sample journey (SJ) patients with BC in Brazil today, with the objective of reviewing existing recommendations based on available scientific evidence and improving preanalytical, analytical, and postanalytical processes in the diagnosis of BC and the determination of HER2 status. The gene discussed is ERBB2; the disease is breast carcinoma.